Genetic endothelial systems biology of sickle stroke risk

Blood

Volumn 111, Issue 7, 2008, Pages 3872-3879

  Milbauer, Liming Chang ^a   Wei, Peng ^a,b   Enenstein, Judy ^a   Jiang, Aixiang ^a,b   Hillery, Cheryl A ^c   Scott, J Paul ^c   Nelson, Stephen C ^a   Bodempudi, Vidya ^a   Topper, James N ^d   Yang, Ruey Bing ^d   Hirsch, Betsy ^a   Pan, Wei ^b   Hebbel, Robert P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; RELA PROTEIN, HUMAN;

ARTICLE; BIOINFORMATICS; BRAIN CIRCULUS ARTERIOSUS; CEREBROVASCULAR ACCIDENT; CHILD; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENETIC DIFFERENCE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; STROKE; VASCULAR DISEASE; ADOLESCENT; ADULT; CELL CULTURE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CIRCLE OF WILLIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; RISK FACTORS; SIGNAL TRANSDUCTION; STROKE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43549114344     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-06-097188     Document Type: Article

References (25)

1. Embury SH, Hebbel RP, Steinberg MH, Mohandas N. Pathogenesis of vasoocclusion. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:311-326.
2. Prengler M, Pavlakis SG, Prohovnik I, Adams RJ. Sickle cell disease: the neurological complications. Ann Neurol. 2002;51:543-552.
3. Ohene-Frempong K, Weiner SJ, Sleeper LA. et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
4. Balkaran B, Char G, Morris JS, et al. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120:360-366.
5. Kinney TR, Sleeper LA, Wang WC, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999:103:640- 645.
6. Adams RJ. McKie VC, Carl EM, et al. Long term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42:699-704.
7. Adams R, McKie VC, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605- 610.
8. Rothman SM, Fulling KH, Nelson JS. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol. 1986;20: 684-690.
9. Aydin F. Do human intracranial arteries lack vasa vasorum? A Comparative immunohistochemical study of intracranial and systemic arteries. Acta Neuropathol (Berlin). 1998;96:22-28.
10. Hoppe C, Klitz W, Noble J, et al. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood. 2003:101:2865-2869.
11. Driscoll MC, Hurlet A, Styles L, et al. Stroke risk in siblings with sickle cell anemia. Blood. 2003;101: 2401-2404.
12. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation. 2004;11:120-151.
13. Sebastiani P, Ramoni MR Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet. 2005;37:435-440.
14. Abboud MR, Cure J, Grangers, et al. STOP study. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004;103:2822-2826.
15. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105: 71-77.
16. Lin Y, Chang L, SoloveyA, et al. Use of blood outgrowth endothelial cells for gene therapy of hemophilia A. Blood. 2002;99:457-462.
17. Irizarry R, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-264.
18. Bolstad BM, Irizarry RA, Åstrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-193.
19. Tusher VJ, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA. 2001:98:5116-5121.
20. Wald A. Note on the consistency of the maximum likelihood estimate. Ann Math Statist. 1949;20: 595-601.
21. Subramanian A, Tamayo P, Mootha VF, et al. Gene set enrichment analysis: a knowledge- based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005:102:15545-15550.
22. National Center for Biotechnology Information. GEO; Gene Expression Omnibus. Accession GSE 9877. Accessed December 18, 2007.
23. Rahman A, Anwar KN, True AL, Malik AB. Thrombin-induced p65 homodimer binding to downstream NF-κB site of the promoter that mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol. 1999;162: 5466-5476.
24. Minami T, Aird WC. Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-κB and GATA motifs. J Biol Chem. 2001; 276:47632-47641.
25. Duan H, Cheng L, Sun X, et al. LFA-1 and VLA-4 involved in human high proliferative potential- endothelial progenitor cells homing to ischemic tissue. Thromb Haemost. 2006;96:807-815.